Kane John M
Department of Psychiatry, The Zucker Hillside Hospital, 75-59 263rd Street, Glen Oaks, NY 11004, USA.
J Clin Psychiatry. 2006;67 Suppl 5:9-14.
Nonadherence to medication is one of the major problems in treating patients with schizophrenia. Clinicians can use a variety of assessment strategies to identify patients who are nonadherent, although none of these is completely reliable. Interventions to improve adherence include psychosocial strategies, second-generation oral antipsychotics, and long-acting injectable antipsychotics. Because of the potential for reduced relapse and rehospitalization rates and the availability of second-generation antipsychotics in injectable form, a case is made for using long-acting injectable second-generation antipsychotics, when appropriate, to treat patients with schizophrenia.
不依从药物治疗是精神分裂症患者治疗中的主要问题之一。临床医生可以使用多种评估策略来识别不依从的患者,尽管这些策略都不完全可靠。改善依从性的干预措施包括心理社会策略、第二代口服抗精神病药物和长效注射用抗精神病药物。鉴于长效注射用第二代抗精神病药物具有降低复发率和再住院率的潜力,且有注射剂型的第二代抗精神病药物可供使用,因此在适当情况下,有理由使用长效注射用第二代抗精神病药物来治疗精神分裂症患者。